109 related articles for article (PubMed ID: 36814373)
1. Service Utilization among Persons Who Inject Drugs Attending a Syringe Exchange Program in New York State.
Beidelman ET; Parker MA; Zoh RS; Owora AH
Subst Use Misuse; 2023; 58(5):649-656. PubMed ID: 36814373
[TBL] [Abstract][Full Text] [Related]
2. Correlates of disparities in syringe return ratios: A cross-sectional study of a syringe services program in New York.
Parker MA; Zoh RS; Nelson EJ; Owora AH
J Subst Abuse Treat; 2021 Feb; 121():108193. PubMed ID: 33357603
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of supervised injection facilities among persons who inject drugs in upstate New York.
Duncan E; Shufelt S; Barranco M; Udo T
Harm Reduct J; 2022 Jul; 19(1):87. PubMed ID: 35907854
[TBL] [Abstract][Full Text] [Related]
4. HIV prevalence, related risk behaviors, and correlates of HIV infection among people who use drugs in Cambodia.
Sopheab H; Chhea C; Tuot S; Muir JA
BMC Infect Dis; 2018 Nov; 18(1):562. PubMed ID: 30424727
[TBL] [Abstract][Full Text] [Related]
5. Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis.
Ballard AM; Falk D; Greenwood H; Gugerty P; Feinberg J; Friedmann PD; Go VF; Jenkins WD; Korthuis PT; Miller WC; Pho MT; Seal DW; Smith GS; Stopka TJ; Westergaard RP; Zule WA; Young AM; Cooper HLF
Harm Reduct J; 2023 Oct; 20(1):157. PubMed ID: 37880724
[TBL] [Abstract][Full Text] [Related]
6. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
7. Assessing seasonality of travel distance to harm reduction service providers among persons who inject drugs.
Allen ST; Ruiz MS; Roess A; Jones J
Harm Reduct J; 2015 Oct; 12():45. PubMed ID: 26458881
[TBL] [Abstract][Full Text] [Related]
8. Is your syringe services program cost-saving to society? A methodological case study.
Des Jarlais DC; Feelemyer J; McKnight C; Knudtson K; Glick SN
Harm Reduct J; 2021 Dec; 18(1):126. PubMed ID: 34876135
[TBL] [Abstract][Full Text] [Related]
9. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
[TBL] [Abstract][Full Text] [Related]
10. Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL.
Bartholomew TS; Onugha J; Bullock C; Scaramutti C; Patel H; Forrest DW; Feaster DJ; Tookes HE
Harm Reduct J; 2020 Jun; 17(1):40. PubMed ID: 32522201
[TBL] [Abstract][Full Text] [Related]
11. Assessing Syringe Exchange Program Access among Persons Who Inject Drugs (PWID) in the District of Columbia.
Allen ST; Ruiz MS; Jones J
J Urban Health; 2016 Feb; 93(1):131-40. PubMed ID: 26786782
[TBL] [Abstract][Full Text] [Related]
12. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
Walters SM; Coston B; Neaigus A; Rivera AV; Starbuck L; Ramirez V; Reilly KH; Braunstein SL
Int J Drug Policy; 2020 Mar; 77():102671. PubMed ID: 32092665
[TBL] [Abstract][Full Text] [Related]
13. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
14. Legal space for syringe exchange programs in hot spots of injection drug use-related crime.
Allen ST; Ruiz MS; Jones J; Turner MM
Harm Reduct J; 2016 Apr; 13():16. PubMed ID: 27112328
[TBL] [Abstract][Full Text] [Related]
15. An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India.
Goswami P; Medhi GK; Armstrong G; Setia MS; Mathew S; Thongamba G; Ramakrishnan L; George B; Singh RK; Paranjape RS; Mahanta J
Int J Drug Policy; 2014 Sep; 25(5):853-64. PubMed ID: 24925819
[TBL] [Abstract][Full Text] [Related]
16. How far will they go? Assessing the travel distance of current and former drug users to access harm reduction services.
Allen S; Ruiz M; O'Rourke A
Harm Reduct J; 2015 Mar; 12():3. PubMed ID: 25889589
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs.
Blackburn NA; Lancaster KE; Ha TV; Latkin CA; Miller WC; Frangakis C; Chu VA; Sripaipan T; Quan VM; Minh NL; Vu PT; Go VF
Harm Reduct J; 2017 Sep; 14(1):62. PubMed ID: 28882143
[TBL] [Abstract][Full Text] [Related]
18. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
[TBL] [Abstract][Full Text] [Related]
19. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.
Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S
Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Factors Associated with Used Syringe Lending Among HIV-Positive Antiretroviral Therapy-Naïve People Who Inject Drugs in a Canadian Setting.
Blumenkrans E; Socías ME; Richardson L; Kerr T; Shoveller J; Montaner J; Milloy MJ
AIDS Behav; 2020 Jul; 24(7):2163-2168. PubMed ID: 32026249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
